CUSIP: 30315R107
Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,822,433
-
Share change
-
-1,088,575
-
Total reported value
-
$71,868,510
-
Put/Call ratio
-
86%
-
Price per share
-
$7.32
-
Number of holders
-
34
-
Value change
-
-$8,746,718
-
Number of buys
-
14
-
Number of sells
-
18
Quarterly Holders Quick Answers
What is CUSIP 30315R107?
CUSIP 30315R107 identifies FSTX - F-STAR THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2021
-
Previous quarter:
Q2 2021
Recent filing periods for CUSIP 30315R107:
Institutional Holders of F-STAR THERAPEUTICS INC - COM (FSTX) as of Q3 2021
As of 30 Sep 2021,
F-STAR THERAPEUTICS INC - COM (FSTX) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,822,433 shares.
The largest 10 holders included
BOXER CAPITAL, LLC, Rock Springs Capital Management LP, Point72 Asset Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, DAFNA Capital Management LLC, JANUS HENDERSON GROUP PLC, Atlas Venture Advisors, Inc., and BlackRock Inc..
This page lists
34
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.